Who We Are

The New Jersey Life Sciences Vendors Alliance (NJLSVA) is a coalition of businesses, individuals and academia who provide goods and services to New Jersey’s life sciences companies.

The NJLSVA was founded to educate suppliers on trends in industry procurement and public policy that affects the life sciences industry.

Choose NJ’s RFP Watch

Choose New Jersey’s RFP Watch provides up-to-date information on business opportunities throughout the Garden State at a cost that is affordable for all companies – with a place of business in New Jersey – large and small.

To learn more click here

NJ Civil Justice Institute to Host ‘FDA Preemption: The Battle for Supremacy’ February 10 in Newark

Trenton, NJ, January 27, 2015 ― A wide variety of products are subject to regulation at the federal level by the Food and Drug Administration (FDA).  But those products are also effectively subject, in varying degrees, to ad hoc regulation at the state level via litigation.  The conflict between these two competing regulatory regimes is a growing concern.

The New Jersey Civil Justice Institute (NJCJI) will host a panel discussion entitled “FDA Preemption: The Battle for Supremacy” that will explore this developing area of law.

The event, which is being sponsored by McCarter & English, will be held on February 10 from Noon to 2:30 p.m. at McCarter & English’s Newark office.

The event will feature Paul Clement of Bancroft PLLC and Gerald Masoudi of Covington & Burling LLP.

Pre-registration is required and space is limited.

The cost to attend is $20 for NJCJI members, government employees & students, and $75 for non-members.  The price includes CLE materials and lunch.  Per BLCE Reg. 302:8, individuals who are experiencing financial hardship may apply to NJCJI for a fee waiver.

For additional information on the February 10 event, including on the presenters, or to register, click here.